Motilal Oswal reiterates Buy on SBI Life Insurance, raises target price to INR2,240

AI Market Summary
SBI Life Insurance posted a strong 1QFY27 with new business APE up 36% YoY and beats across APE, VNB and shareholder PAT, while embedded value rose 15% YoY. Motilal Oswal reiterated a BUY and raised its target price, citing sustained operating RoEV assumptions. The news is supportive for Indian financial-sector risk sentiment but has limited broader cross-asset impact.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+0.77%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
SBI Life Insurance reported 1QFY27 new business annualized premium equivalent (APE) of INR53.8b, up 36% year on year and 10% above expectations. Embedded value (EV) stood at INR852.9b at the end of 1QFY27, rising 15% year on year, while shareholder profit after tax rose 22% to INR7.2b, beating estimates by 7%. Motilal Oswal reiterated its BUY rating and raised its target price to INR2,240, based on 2x FY28E P/EV.